Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669603 · ClinicalTrials.gov registry record · NA
Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 789
- Enrollment target
NCT01669603 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 789 participants.
The verdict
NCT01669603, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 789 participants
- Enrollment target
Study Summary
The study is designed to assess the effect of ingestion of a probiotic on innate and adaptive host responses to rhinovirus infection.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Bifidobacterium lactis Bl-04
- BIOLOGICAL Rhinovirus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 789 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01669603
The ClinicalTrials.gov registry entry for NCT01669603 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 789 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01669603 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01669603 about?
NCT01669603 is a clinical study titled "Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR)". The study is designed to assess the effect of ingestion of a probiotic on innate and adaptive host responses to rhinovirus infection.
What is the current status of trial NCT01669603?
This trial is currently completed. It is a NA study. The enrollment target is 789 participants. The study started on 2012-08. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01669603?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Bifidobacterium lactis Bl-04 (DIETARY_SUPPLEMENT), Rhinovirus (BIOLOGICAL).
Who is sponsoring clinical trial NCT01669603?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.